CELG up +1.34% percent Today $CELG High is at 105.49 and

New Post Public Reply Private Reply Replies (0) Message Board
Lucky Jimmy
CELG up +1.34% percent Today $CELG High is at 105.49 and the Low 103.26 with current volume of 667,845.

Recent News posted below.

Celgene Corp CELG other info.
http://investorshangout.com/Celgene-Corporation-CELG-53644/

CELG Celgene Corp Recent Headline News

Early Glance: Biotechnology companies
AP - 48 mins ago
NEW YORK (AP) — Shares of some top biotechnology companies are mixed at 10 a.m.:
GILD: 101.07 (-0.99), AMGN: 159.34 (+1.66), CELG: 105.00 (+0.95)

Moffitt Cancer Center Announces Development of Experimental Treatment for Myelodysplastic Syndromes, Autoimmune Diseases
Business Wire - 2 hrs 16 mins ago
In a major step to treat patients living with Myelodysplastic Syndromes (MDS), a group of diseases that affect the bone marrow and blood, Moffitt Cancer Center today announced the development of an innovative investigational biologic agent that could improve patient response and outcomes for MDS and other diseases.
CELG: 105.00 (+0.95), CELGZ: 3.29 (+0.01)

Why Top Dividend Stock Johnson & Johnson Could Plunge in 2015
George Budwell, The Motley Fool - Motley Fool - Mon Nov 17, 7:13AM CST
As the healthcare sector rolls through its third-quarter earnings, a bucolic picture is coming into focus. Earnings across the sector are soaring due to new drug launches, a frenzy of acquisitions, and vast reorganizations that have helped to stem...
JNJ: 108.29 (+0.13), GILD: 101.07 (-0.99), ABBV: 65.18 (+1.18), CELG: 105.00 (+0.95)

'Fast Money' Recap: Was Friday the Start of a Bull Rally in Gold?
at The Street - Sat Nov 15, 4:00AM CST
The trading panel took a look at gold prices, which climbed 2.3% on Friday, as well as the potential for a pullback in biotech stocks.
AMZN: 320.27 (-7.55), TSRO: 30.43 (+0.81), XBI: 170.32 (+2.40), IBB: 291.26 (+3.09), CELG: 105.00 (+0.95), GILD: 101.07 (-0.99), GLD: 113.88 (-0.59), MCD: 95.85 (-0.36), SLV: 15.43 (-0.20), GDX: 19.06 (+0.04), TWTR: 40.94 (-0.91), AAPL: 114.24 (+0.06), BABA: 114.60 (-0.50)

Medical Stocks Tumble But Most Of IBD 50 Trading Well
at Investor's Business Daily - Fri Nov 14, 5:47PM CST
A few medical leading stocks have slid, but otherwise the IBD 50 remained in good shape last week. Illumina (ILMN) and Akorn (AKRX) have fallen below their buy points, while Alexion Pharmaceuticals (ALXN) and Celgene (CELG) exhibited some weakness of...
AKRX: 38.94 (+0.73), ALXN: 189.14 (+0.38), FFIV: 127.45 (-1.43), ILMN: 182.21 (+1.71), SPR: 41.12 (-0.08), AAPL: 114.24 (+0.06), ATHM: 43.17 (-1.41), BITA: 89.00 (-2.91), CELG: 105.00 (+0.95)

Final Glance: Biotechnology companies
AP - Fri Nov 14, 5:03PM CST
NEW YORK (AP) — Shares of some top biotechnology companies were down at the close of trading:
GILD: 101.07 (-0.99), AMGN: 159.34 (+1.66), CELG: 105.00 (+0.95)

Look for Shares of Celgene to Potentially Rebound after Yesterday's 3.15% Sell Off
Comtex SmarTrend(R) - Fri Nov 14, 3:41PM CST
Celgene (NASDAQ:CELG) traded in a range yesterday that spanned from a low of $102.13 to a high of $107.65. Yesterday, the shares fell 3.1%, which took the trading range below the 3-day low of $106.54 on volume of 7.8 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
CELG: 105.00 (+0.95)

Watch for Celgene to Potentially Rebound After Falling 3.15% Yesterday
Comtex SmarTrend(R) - Fri Nov 14, 3:41PM CST
Celgene (NASDAQ:CELG) traded in a range yesterday that spanned from a low of $102.13 to a high of $107.65. Yesterday, the shares fell 3.1%, which took the trading range below the 3-day low of $106.54 on volume of 7.8 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
CELG: 105.00 (+0.95)

Stock Market Treads Water; Earnings Drive BitAuto
at Investor's Business Daily - Fri Nov 14, 3:21PM CST
Stocks struggled for direction for most of the day Friday amid upbeat data on retail sales and consumer sentiment. But the main indexes ultimately ended mildly higher. The Nasdaq edged up 0.2%, thanks to strength in software and solar issues. But...
NTES: 100.42 (-0.22), ILMN: 182.21 (+1.71), BITA: 89.00 (-2.91), CELG: 105.00 (+0.95)

Synageva Up on New Phase III Data on Sebelipase Alfa - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Nov 14, 2:40PM CST
Synageva BioPharma Corp. (GEVA) announced the presentation of new data from a phase III study on sebelipase alfa for LAL deficiency.
GEVA: 77.82 (+2.56), AKRX: 38.94 (+0.73), ADHD: 3.45 (-0.21), CELG: 105.00 (+0.95)

Stocks Drift Lower As Biotechs Tumble
at Investor's Business Daily - Fri Nov 14, 1:48PM CST
Stocks drifted mostly lower Friday with a little more than one hour left in the session, with medical stocks leading the way down. Volume in the stock market today was running lighter than Thursday's levels. The Nasdaq rose less than 0.1%, the S&P...
BIIB: 306.53 (+1.10), NTES: 100.42 (-0.22), HAL: 50.81 (-4.27), BITA: 89.00 (-2.91), BHI: 67.00 (+7.11), CELG: 105.00 (+0.95)

Stocks Mixed; Amazon Jumps On Book Deal
at Investor's Business Daily - Fri Nov 14, 12:32PM CST
Stocks were mixed, but gained a small amount of ground in afternoon trading Friday. A better-than-expected retail sales report lifted Wall Street spirits in the stock market today. The Nasdaq gained 0.1%; the Dow Jones industrial average dropped...
BIIB: 306.53 (+1.10), AMZN: 320.27 (-7.55), HAL: 50.81 (-4.27), ILMN: 182.21 (+1.71), BITA: 89.00 (-2.91), BHI: 67.00 (+7.11), CELG: 105.00 (+0.95)

Midday Glance: Biotechnology companies
AP - Fri Nov 14, 12:17PM CST
NEW YORK (AP) — Shares of some top biotechnology companies are down at 1 p.m.:
GILD: 101.07 (-0.99), AMGN: 159.34 (+1.66), CELG: 105.00 (+0.95)

Stocks Flat While Medical Issues Tumble
at Investor's Business Daily - Fri Nov 14, 11:04AM CST
Stocks were mixed and mostly unchanged going into the lunch hour Friday after a slightly-better-than-expected retail sales report lifted optimism in the stock market today. The Nasdaq rose 0.1%, while the S&P 500 and the Dow Jones industrial average...
SINA: 39.07 (-0.73), WB: 18.87 (-0.06), TUBE: 15.67 (-1.28), BITA: 89.00 (-2.91), CELG: 104.98 (+0.93)

Biotech off today led by Biogen
Seeking Alpha - at Seeking Alpha - Fri Nov 14, 11:00AM CST

BIIB: 306.53 (+1.10), VRTX: 111.98 (+0.64), GILD: 101.07 (-0.99), ALXN: 189.14 (+0.38), AMGN: 159.34 (+1.66), IBB: 291.28 (+3.11), REGN: 406.69 (+11.49), CELG: 104.98 (+0.93)

Equity Coverage on Biotech Industry - Gilead Sciences, MannKind, ARIAD Pharma, iBio Inc., and Celgene
PR Newswire - Fri Nov 14, 8:10AM CST
Investor-Edge has initiated coverage on the following equities: Gilead Sciences Inc. (NASDAQ: GILD), MannKind Corporation (NASDAQ: MNKD), ARIAD Pharmaceuticals Inc. (NASDAQ: ARIA), iBio Inc. (NYSE MKT: IBIO), and Celgene Corporation (NASDAQ: CELG). Free research on these five companies can be accessed at: http://investor-edge.com/register. The US markets on Thursday, November 13, 2014, ended on a positive note as the Dow Jones Industrial Average finished at 17,652.79, up 0.23% and the NASDAQ Composite closed at 4,680.14, up 0.11%. The S&P 500 finished the session 0.05% higher at 2,039.33. During the trading session, four out of ten sectors finished on a higher note. The S&P 500 Health Care Sector Index ended the day at 783.78, down 0.10%, whereas the index has gained 10.85% in the previous three months. Register for your complimentary reports on these five stocks at:
GILD: 101.07 (-0.99), IBIO: 1.11 (+0.06), ARIA: 6.06 (-0.09), MNKD: 6.17 (+0.01), CELG: 104.98 (+0.93)

Sarepta Initiates Dosing for Study Evaluating Eteplirsen - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Nov 13, 4:40PM CST
Sarepta (SRPT) announced that it has enrolled the first patient in an open label study on eteplirsen in non-ambulant Duchenne muscular dystrophy patients.
RNA: 11.32 (+0.05), SRPT: 15.23 (-0.09), ILMN: 182.20 (+1.70), CELG: 104.98 (+0.93)

Ligand/Glaxo Seek EU Nod for Severe Aplastic Anemia Drug - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Nov 13, 4:00PM CST
Ligand Pharma (LGND) announced the submission of a Marketing Authorisation Application to the European Medicines Agency by its partner GlaxoSmithKline for Revolade.
LGND: 57.78 (-0.01), ILMN: 182.10 (+1.60), GSK: 45.90 (+0.16), CELG: 104.98 (+0.93)

Celgene Corporation (CELG) Stock Research Links

CELG Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

HearUSA Expands Access with AI-Powered Hearing Aids

Updated Category News Views 130

AI Revolution in Hearing Care Look, the hearing aid industry isn't known for headlines that grab you by the throat, but HearUSA just tossed a proverbial grenade into the scene with Widex Allure AI RIC. This is more than a slight tweak in hearing tech—it's a game-changer. We're talking about on-demand AI noise management blended with Widex's renowned natural sound. It's...

Continue Reading
SiteOne Joins S&P SmallCap 600 Amid KKR's Integer Buyout

Updated Category News Views 50

Changes on the SmallCap Horizon Starting off, SiteOne Landscape Supply (NYSE: SITE) is hopping onto the S&P SmallCap 600 bandwagon. This shift activates just as the market revs up on November 19, 2026. SiteOne is stepping in as Integer Holdings Corp. (NYSE: ITGR) makes its grand exit, a move prompted by a significant acquisition by KKR & Co. Inc. (NYSE: KKR). KKR’s...

Continue Reading
Caladan Partners with Anchorage for Stronger Trading

Updated Category News Views 75

Caladan and Anchorage Unite for Asset Growth Man, partnerships might just be the secret sauce we never know we need until it’s on our plate. It's a fresh day in digital trading, and Caladan just shook things up by teaming up with Anchorage Digital, bolstering their trading and settlement capabilities to satisfy the big players. If there's one thing that's hot as a...

Continue Reading
191 Schools Honored for Academic Growth Success

Updated Category News Views 99

Celebrating Educational Progress Nationwide In a world where numbers fly off the stock tickers and translate into dollar signs in some corner office, it's refreshingly humbling to find real gains being celebrated in the educational sector. Curriculum Associates has tipped their hat to 191 schools that have done something remarkable: they've pushed students to stretch...

Continue Reading
Go NYC's Perks: Making Commutes Rewarding in NYC

Updated Category News Views 50

Go NYC's Perks: Turning Commutes into Gains I’ve seen a lot of schemes aimed at getting folks to change their travel habits, but this one from Go NYC caught my attention. These guys are trying to squeeze some extra value out of the daily grind for anyone hoofing it across the Big Apple. A new rewards program named Perks kicks off, offering all kinds of discounts and...

Continue Reading
Luxury Villa Cashback Offers Entice Travelers in November

Updated Category News Views 49

A November Bonanza for Villa Bookings Who doesn't love having a few extra bucks in their pocket, especially when they come with the allure of luxury travel? Villas of Distinction is rolling out what they call a 'November Cashback Offer,' and for those with the wallet—and wanderlust—to match, it could be a tempting proposition. Hanging the bait of up to $2,000 cashback...

Continue Reading
WirelessCar Rebrands to Reinforce Connected Mobility Vision

Updated Category News Views 122

Evolving Identity for Changing Times Let’s dive right into it—WirelessCar, a name that’s struck chords in the automotive trenches for ages, is taking a bold step by unveiling a new brand identity. Now, don’t roll your eyes just yet. This isn’t another company tapping the rebranding siren for the heck of it. We’re talking about a company that’s been in the...

Continue Reading
Stark Future Amasses €150M, Revving Up Electric Bike Dominance

Updated Category News Views 142

Well, if you've been keeping your eye on electric vehicles, this is a story that might raise those eyebrows. Stark Future, a name perhaps not buzzing on every street just yet, has gone and done it—snagged over €150 million in fresh capital. Breaking Barriers with Record-breaking Numbers Stark Future didn't just make a ripple; they caused a tsunami. This buzzing...

Continue Reading
Guangdong-US Trade: LED Screens, Beef & Trust Make Waves

Updated Category News Views 81

Guangdong's Economic Ballet with the U.S. Grab a cup of coffee, and let's unravel how Guangdong and the U.S. are tangoing their way through trade like nobody's business! Guangdong, the heavyweight champ for U.S.-China trade transactions, notched up a cool 685.27 billion yuan ($102 billion) in the first eight months of 2026. That's a healthy jump of 6.9% year on year, mind...

Continue Reading
Sovereign Crown Vault's Auction Draws Numismatic Collectors

Updated Category News Views 54

A Legendary Auction with Three Generations of Passion Coins, eh? They might just be small metallic disks to the untrained eye, but these suckers tell stories that stretch beyond any bank ledger. Sovereign Crown Vault LLC knows this, and they’re gearing up for quite the show on November 22, 2026. Their Holiday Season Kickoff Spectacular is about to lure in collectors...

Continue Reading

Top 5 Most Recently Viewed Articles

Huawei's Innovative Energy Solutions Drive Renewable Power Growth

Updated Category News Views 184

Transforming Energy Solutions with Huawei Digital Power At a prominent event in Germany, Huawei Digital Power made waves by showcasing cutting-edge solar and energy storage technologies. The company hosted an important launch event under the title "Smart PV & ESS: Powering a Grid Forming Future," emphasizing their commitment to advancing renewable energy solutions. With...

Continue Reading
Carlyle Credit Income Fund's NAV Insights and Latest Developments

Updated Category News Views 225

Understanding Carlyle Credit Income Fund's Latest NAV Report Carlyle Credit Income Fund (NYSE: CCIF) has recently unveiled its unaudited net asset value (NAV) per common share, reporting this figure as $7.64. This information was shared through a filing with the Securities and Exchange Commission, indicating the fund's current fiscal status. The announcement is important...

Continue Reading
Tuya Inc. to Announce Q4 and Fiscal Year 2025 Results Soon

Updated Category News Views 140

Tuya Inc. to Release Financial Results for Q4 and Fiscal Year 2025 Tuya Inc. (NYSE: TUYA), a prominent AI cloud platform service provider, has announced that it will share its fourth quarter and preliminary fiscal year 2025 financial results shortly after the market closes during the first week of March. This is a significant event for the company as it highlights the...

Continue Reading
Geopolitical Tensions Influence Oil Prices: Market Insights

Updated Category News Views 154

Current Oil Market Dynamics Amid Global Tensions Crude prices have shown significant resilience following earlier losses, positioning themselves for a potential third consecutive day of gains. As geopolitical tensions continue to escalate, the latest developments in the Middle East are fueling market reactions. Iran's Potential Military Actions and Market Implications...

Continue Reading
Antimony Market Growth: A Multi-Billion Dollar Future Ahead

Updated Category News Views 221

The Rising Antimony Market: A New Era of Opportunities Antimony minerals, primarily sourced from stibnite and its various forms, play a crucial role in multiple industries due to their unique properties such as flame retardancy and alloy formation. As societies continue to focus on enhancing safety in various applications, particularly in construction and automotive, the...

Continue Reading